|
Link Pharma Chem Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
16.23 Cr.
|
P/BV
|
1.28
|
Book Value (Rs.)
|
28.51
|
|
52 Week High/Low (Rs.)
|
51/28
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -2.31 | -3.07 | 1.47 | 4.24 | 2.44 |
| Diluted EPS (Rs.) | -2.31 | -3.07 | 1.47 | 4.24 | 2.44 |
| Cash EPS (Rs.) | -0.19 | -0.74 | 3.55 | 6.33 | 4.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 28.51 | 30.87 | 33.87 | 32.60 | 28.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 28.51 | 30.87 | 33.87 | 32.60 | 28.29 |
| Revenue From Operations / Share (Rs.) | 57.27 | 67.33 | 87.28 | 120.61 | 78.40 |
| PBDIT / Share (Rs.) | 0.71 | -0.02 | 5.79 | 9.01 | 6.74 |
| PBIT / Share (Rs.) | -1.41 | -2.35 | 3.71 | 6.92 | 4.77 |
| PBT / Share (Rs.) | -3.16 | -4.31 | 2.00 | 5.90 | 3.78 |
| Net Profit / Share (Rs.) | -2.31 | -3.07 | 1.47 | 4.24 | 2.44 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 1.24 | -0.03 | 6.63 | 7.46 | 8.59 |
| PBIT Margin (%) | -2.46 | -3.49 | 4.25 | 5.73 | 6.08 |
| PBT Margin (%) | -5.51 | -6.40 | 2.28 | 4.89 | 4.82 |
| Net Profit Margin (%) | -4.03 | -4.55 | 1.68 | 3.51 | 3.11 |
| Return on Networth / Equity (%) | -8.11 | -9.94 | 4.34 | 12.99 | 8.63 |
| Return on Capital Employeed (%) | -4.73 | -6.98 | 9.18 | 16.74 | 12.64 |
| Return On Assets (%) | -4.41 | -5.25 | 2.01 | 6.49 | 4.14 |
| Long Term Debt / Equity (X) | 0.03 | 0.07 | 0.13 | 0.20 | 0.25 |
| Total Debt / Equity (X) | 0.45 | 0.67 | 0.58 | 0.44 | 0.25 |
| Asset Turnover Ratio (%) | 1.03 | 1.02 | 1.26 | 1.94 | 1.54 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.11 | 1.05 | 1.21 | 1.28 | 1.62 |
| Quick Ratio (X) | 0.53 | 0.48 | 0.36 | 0.83 | 1.35 |
| Inventory Turnover Ratio (X) | 1.88 | 1.56 | 3.11 | 10.45 | 8.69 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.40 | -0.01 | 3.38 | 8.87 | 6.80 |
| Interest Coverage Ratio (Post Tax) (%) | -0.32 | -0.56 | 1.86 | 5.17 | 3.46 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 20.73 | 27.82 | 24.82 | 23.38 | 8.81 |
| EV / Net Operating Revenue (X) | 0.81 | 0.93 | 0.64 | 0.43 | 0.25 |
| EV / EBITDA (X) | 65.63 | -2928.74 | 9.66 | 5.84 | 2.94 |
| MarketCap / Net Operating Revenue (X) | 0.59 | 0.62 | 0.41 | 0.33 | 0.30 |
| Price / BV (X) | 1.19 | 1.36 | 1.08 | 1.23 | 0.83 |
| Price / Net Operating Revenue (X) | 0.59 | 0.62 | 0.41 | 0.33 | 0.30 |
| EarningsYield | -0.06 | -0.07 | 0.04 | 0.10 | 0.10 |
